【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2012 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2012 9
2.2.1 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 9
2.2.2 Teva Pharma Completes Public Offering of Notes for $2 Billion 9
2.2.3 HCA Completes Public Offering of Notes Due 2021 for $1 Billion 10
2.2.4 Mylan Prices Private Placement of Notes Due 2023 for $750 Million 10
2.2.5 Mitsubishi Chemical to Acquire Qualicaps from Carlyle Group for $660 Million 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2012 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2012 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2012 13
3.1.1 Top M&A Deals in December 2012 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2012-December 2012 14
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2012 15
3.2.1 Top Equity Offering Deals in December 2012 16
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2012 – December 2012 16
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2012 17
3.3.1 Top PE/VC Deals in December 2012 18
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2012 19
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2012 20
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2012 – December 2012 21
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2012 – December 2012 22
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2012 – December 2012 24
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2012 25
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2012 25
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 26
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2012 – December 2012 27
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2012 – December 2012 28
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 29
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2012 31
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2012 32
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2012 32
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2012 33
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2012 – December 2012 34
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 35
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2012 – December 2012 36
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 37
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 39
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2012 39
6.1.1 Oncology – Deals of the Month 40
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2012 41
6.2.1 Central Nervous System – Deals of the Month 42
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2012 43
6.3.1 Infectious Diseases – Deals of the Month 44
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2012 45
6.4.1 Metabolic Disorders – Deal of the Month 46
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2012 47
6.5.1 Immunology – Deal of the Month 48
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2012 49
6.6.1 Cardiovascular – Deal of the Month 50
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, December 2012 51
6.7.1 Gastrointestinal – Deals of the Month 52
7 Deal Summary by Geography 53
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2012 53
7.1.1 North America – Deals of the Month 54
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2012 55
7.2.1 Europe – Deals of the Month 56
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2012 57
7.3.1 Asia-Pacific – Deals of the Month 58
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2012 59
7.4.1 Rest of the World – Deals of the Month 60
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 61
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2012 – December 2012 61
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2012 – December 2012 62
9 Further Information 63
9.1 Methodology 63
9.2 About GlobalData 64
9.3 Contact Us 64
9.4 Disclosure information 64
9.5 Disclaimer 64
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2012（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals
■ 発行日：2013年1月14日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160054
■ 調査対象地域：グローバル
- ハラール食品の世界市場ABSTRACTAbout Halal Food Halal in Arabic means permissible. Halal foods are the food products that adhere to the Islamic laws and follow Islamic pattern of slaughtering. Technavio’s analysts forecast the global halal food market to grow at a CAGR of 15.52% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global halal food …
- 心室頻拍(Ventricular Tachycardia)：世界の治験レビュー（2015年上半期版）Ventricular Tachycardia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2015" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers …
- 粉体塗料の世界市場2019-2023115 pages, November 2018 About this market The manufacturers of powder coatings are focusing on sustainability to reduce adverse environmental impacts. As powder coatings do not require solvents and are thus environmentally safe. Powder coatings are safe for the environment and are thus used across industrial applications. Concerns regarding the sustainability of coating products have increased th …
- インシデント対応の世界市場：コンポーネント別（ソリューション、サービス）、サービス別、セキュリティタイプ別、導入モード別、組織規模別、地域別予測Global Incident Response Market to reach USD 48 billion by 2025. Global Incident Response Market valued approximately USD 9.30 billion in 2016 is anticipated to grow with a healthy growth rate of more than 20% over the forecast period 2017-2025. Stringent government regulations and compliances requirements, growing level of cyber-attacks, and heavy financial losses post incident occurrence have le …
- インターネット通販のグローバル市場：市場ダイナミクス、ネットトレンド、競争環境Summary The “Global Online Retailing, 2013-2018” report, published by Conlumino, provides an analysis of current and forecast market data of retail sales in different category groups in online retail channel across the globe. In addition, it covers information on key technology trends, online trends in major countries and payment preferences of consumers. Also focuses major retailers across the re …
- 世界のスルホサクシネート市場2015The Global Sulfosuccinate Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Sulfosuccinate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sulfosuccinate market analysis is provided for the international markets including development trends, compe …
- 化学防護服の世界市場予測There are numerous chemicals in an industrial working environment which can affect unprotected skin of a person. These toxic chemical may come in contact with the dermatitis layer present on the skin and can enter into human body, which adversely affect the human body. The use of chemical protective clothing can reduce the risk of exposure to hazardous chemicals and provide the last line of defens …
- スマートエアポート建設の世界市場ABSTRACTAbout Smart Airport Construction Smart airports make systems and processes digitally aware, interconnected, infused with intelligence, and easily accessible by users. The prime idea behind the development of smart airports is to create an integrated system and a unified and ready-to-use digital platform for airports to become intelligent and informed. Technavio’s analysts forecast the glob …
- アルコール依存症(Alcohol Addiction)：世界の治験レビュー（2015年上半期版）Alcohol Addiction Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H1, 2015" provides data on the Alcohol Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alcohol Addiction. It includes an overview of the trial numbers and their recruitment s …
- フランスの分子診断・検査市場2014This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment Market Structure Market Size, Growth, and Major Suppliers' Market Shares List of TablesMolecu …
- Erbitux：大腸癌治療薬市場分析Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on h …
- エンタープライズアプリケーションSIの世界市場2015-2019About Global Enterprise Application System Integration Businesses worldwide depend on technology and integration solutions to sustain smooth business operations and drive revenue growth. Innovative IT applications and integrated solutions have enriched businesses functions. Enterprise application system integration has become a key enabler for streamlining business functions. Going forward, this t …
- 2型糖尿病：グローバル臨床試験レビュー（2014年上半期）Type 2 Diabetes Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Type 2 Diabetes Global Clinical Trials Review, H1, 2014" provides data on the Type 2 Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as …
- マレーシアの健康サプリメント市場2015-2019Technavio’s research analyst predicts the health supplement market in Malaysia to grow at a CAGR of 7% during the forecast period. The rise in the aging population in Malaysia is the key driver for the market growth of this region. Products that prevent age-related disorders, such as those linked to the digestive system, and ones that help maintain blood sugar levels, are in high demand among this …
- ろう付材料の世界市場：銀ろう、金ろうAbout Silver and Gold-based Brazing Materials Brazing is defined as the process of joining two metals by deploying a filler metal such as a brazing alloy. In the brazing process, the filler metal is heated slightly above its melting point and allowed to flow through capillary action in between the two base metals that require to be joined. This process is normally undertaken by using a controlled …
